aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Twist Bioscience, founded in 2013, is a biotechnology company dedicated to advancing synthetic DNA technology. Its core mission is to drive biological innovations that make the world safer, healthier, and more sustainable. The company offers a range of DNA-based tools and services, including gene synthesis, DNA libraries, and data storage solutions. Twist Bioscience focuses on various markets such as drug discovery, cancer research, human genetics, agricultural biotechnology, animal health, and infectious disease research.
Notable figures associated with Twist Bioscience include co-founder and CEO Emily Leproust. The company has attracted significant investment from prominent venture capital firms and has achieved key milestones such as developing high-throughput DNA synthesis platforms. Twist Bioscience's impact is evident in its contributions to groundbreaking scientific research and its role in enabling advancements across multiple disciplines.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Synthetic DNA
Technology
Biotech
Tags
Biotech, Data
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Government
Geographic Exposure
United States
When was Twist Bioscience founded?
Twist Bioscience was founded in 2013.
Where is Twist Bioscience's headquarters located?
Twist Bioscience's headquarters is located in South San Francisco, CA, US.
When was Twist Bioscience's last funding round?
Twist Bioscience's most recent funding round was for $250M (USD) in February 2022.
How many employees does Twist Bioscience have?
Twist Bioscience has 989 employees as of Feb 6, 2024.
How much has Twist Bioscience raised to-date?
As of July 05, 2023, Twist Bioscience has raised a total of $553.1M (USD) since Feb 10, 2022.
Add Comparison
Total Raised to Date
$553.1M
USD
Last Update Feb 10, 2022
Last Deal Details
$250M
USD
Feb 10, 2022
Post Ipo Equity
Total Employees Over Time
989
As of Feb 2024
Twist Bioscience Address
681 Gateway Blvd
South San Francisco,
California
94080
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts